Quent Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$177K Sell
605
-318
-34% -$105K 0.01% 413
2025
Q4
$324K Sell
923
-256
-22% -$86.5K 0.02% 297
2025
Q3
$381K Buy
1,179
+8
+0.7% +$2.49K 0.03% 181
2025
Q2
$455K Sell
1,171
-109
-9% -$43.8K 0.04% 160
2025
Q1
$557K Sell
1,280
-208
-14% -$83.5K 0.06% 124
2024
Q4
$549K Buy
1,488
+30
+2% +$12.6K 0.06% 134
2024
Q3
$759K Sell
1,458
-24
-2% -$12.8K 0.08% 137
2024
Q2
$803K Buy
1,482
+58
+4% +$30.7K 0.09% 119
2024
Q1
$739K Sell
1,424
-4
-0.3% -$1.99K 0.09% 132
2023
Q4
$673K Buy
1,428
+117
+9% +$54.1K 0.09% 131
2023
Q3
$571K Sell
1,311
-27
-2% -$12.2K 0.09% 131
2023
Q2
$594K Sell
1,338
-31
-2% -$14.3K 0.09% 132
2023
Q1
$630K Sell
1,369
-31
-2% -$14.8K 0.11% 118
2022
Q4
$719K Buy
1,400
+40
+3% +$20.3K 0.13% 101
2022
Q3
$618K Buy
1,360
+133
+11% +$63.6K 0.13% 104
2022
Q2
$592K Buy
1,227
+12
+1% +$5.94K 0.13% 104
2022
Q1
$597K Sell
1,215
-963
-44% -$440K 0.11% 126
2021
Q4
$1.01M Buy
+2,178
New +$916K 0.21% 78

Other funds holding ELV

Quent Capital's ELV Position: Q1 2026 in Review

Quent Capital reduced its Elevance Health (ELV) stake by 34% in Q1 2026, selling an estimated $105K and leaving 605 shares worth $177K. The position accounts for 0.01% of the portfolio, ranked #413.

Quent Capital first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.01M in Q4 2021. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Quent Capital held 605 shares of Elevance Health worth $177K as of Q1 2026.
  • Quent Capital sold 318 Elevance Health shares in Q1 2026, an estimated $105K.
  • Elevance Health made up 0.01% of Quent Capital's portfolio in Q1 2026, its #413 holding.
  • Quent Capital first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's Elevance Health position peaked at $1.01M in Q4 2021.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.